Laboratory Corp. of America Holdings (LH) Social Stream
LABORATORY CORP OF AMERICA HOLDINGS (LH) Price Targets From Analysts
Use the tables below to see what analysts covering LABORATORY CORP OF AMERICA HOLDINGS think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 11 | $380 | $245 | $326.7 | $228.19 | 43.17% |
| 2021-11-15 | 11 | $377 | $245 | $325.7 | $228.19 | 42.73% |
| 2021-12-09 | 12 | $377 | $245 | $326.7 | $228.19 | 43.17% |
| 2021-12-17 | 12 | $380 | $245 | $328.181 | $228.19 | 43.82% |
| 2022-01-06 | 12 | $380 | $245 | $330.181 | $228.19 | 44.7% |
| 2022-01-18 | 10 | $380 | $278 | $340.1 | $228.19 | 49.04% |
| 2022-01-31 | 9 | $380 | $278 | $336.5 | $228.19 | 47.46% |
| 2022-02-10 | 10 | $380 | $278 | $336.5 | $228.19 | 47.46% |
| 2022-02-11 | 10 | $380 | $294 | $340.888 | $228.19 | 49.39% |
| 2022-02-13 | 10 | $370 | $294 | $338.666 | $228.19 | 48.41% |
| 2022-04-04 | 9 | $370 | $294 | $338.666 | $228.19 | 48.41% |
| 2022-04-12 | 9 | $370 | $294 | $343.5 | $228.19 | 50.53% |
| 2022-04-28 | 9 | $370 | $294 | $342.571 | $228.19 | 50.13% |
| 2022-05-03 | 9 | $360 | $294 | $333.5 | $228.19 | 46.15% |
| 2022-05-12 | 9 | $360 | $265 | $326 | $228.19 | 42.86% |
| 2022-06-01 | 8 | $350 | $265 | $318.5 | $228.19 | 39.58% |
| 2022-06-19 | 8 | $350 | $265 | $316 | $228.19 | 38.48% |
| 2022-07-19 | 8 | $340 | $265 | $311.625 | $228.19 | 36.56% |
| 2022-07-29 | 9 | $340 | $265 | $311.625 | $228.19 | 36.56% |
| 2022-09-10 | 9 | $340 | $265 | $304.5 | $228.19 | 33.44% |
| 2022-09-17 | 10 | $340 | $265 | $304.5 | $228.19 | 33.44% |
| 2022-10-05 | 10 | $340 | $260 | $298.25 | $228.19 | 30.7% |
| 2022-10-27 | 10 | $340 | $260 | $292.625 | $228.19 | 28.24% |
| 2022-10-31 | 10 | $340 | $260 | $283.875 | $228.19 | 24.4% |
| 2022-11-15 | 10 | $340 | $250 | $276.875 | $228.19 | 21.34% |
| 2022-12-12 | 11 | $340 | $250 | $273.888 | $228.19 | 20.03% |
| 2023-01-04 | 10 | $290 | $250 | $265.625 | $228.19 | 16.41% |
| 2023-01-05 | 10 | $290 | $250 | $267.5 | $228.19 | 17.23% |
| 2023-01-06 | 10 | $303 | $250 | $269.125 | $228.19 | 17.94% |
| 2023-01-27 | 11 | $303 | $250 | $270.888 | $228.19 | 18.71% |
| 2023-02-08 | 10 | $303 | $250 | $270.888 | $228.19 | 18.71% |
| 2023-02-16 | 10 | $303 | $250 | $273.666 | $228.19 | 19.93% |
| 2023-02-20 | 12 | $295 | $250 | $272.777 | $228.19 | 19.54% |
| 2023-02-21 | 12 | $295 | $250 | $278.5 | $228.19 | 22.05% |
| 2023-04-12 | 12 | $295 | $250 | $281.2 | $228.19 | 23.23% |
| 2023-04-26 | 12 | $295 | $235 | $273.2 | $228.19 | 19.72% |
| 2023-05-01 | 12 | $295 | $235 | $272.2 | $228.19 | 19.29% |
| 2023-05-15 | 12 | $290 | $235 | $271.2 | $228.19 | 18.85% |
| 2023-07-18 | 12 | $290 | $235 | $269.2 | $228.19 | 17.97% |
| 2023-07-27 | 12 | $290 | $235 | $266 | $228.19 | 16.57% |
| 2023-08-01 | 12 | $290 | $215 | $263 | $228.19 | 15.25% |
| 2023-08-02 | 12 | $290 | $215 | $259.6 | $228.19 | 13.76% |
| 2023-08-15 | 12 | $290 | $215 | $256 | $228.19 | 12.19% |
| 2023-09-05 | 12 | $285 | $215 | $254 | $228.19 | 11.31% |
| 2023-09-19 | 12 | $285 | $210 | $250 | $228.19 | 9.56% |
| 2023-09-20 | 13 | $285 | $210 | $250 | $228.19 | 9.56% |
| 2023-10-16 | 12 | $285 | $210 | $248.166 | $228.19 | 8.75% |
| 2023-10-30 | 12 | $270 | $210 | $244 | $228.19 | 6.93% |
| 2023-11-20 | 12 | $270 | $210 | $241.75 | $228.19 | 5.94% |
| 2023-12-05 | 12 | $270 | $210 | $242.75 | $228.19 | 6.38% |
| 2023-12-12 | 12 | $270 | $210 | $242.333 | $228.19 | 6.2% |
| 2023-12-19 | 12 | $270 | $210 | $243.166 | $228.19 | 6.56% |
| 2023-12-27 | 12 | $270 | $210 | $244.25 | $228.19 | 7.04% |
| 2023-12-29 | 13 | $270 | $210 | $244.25 | $228.19 | 7.04% |
The Trend in the Analyst Price Target
Over the past 94 days, LH's average price target has gone down $3.92.
LH reports an average of 17.97% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-21 | 12 | 295 | 250 | 274.500 | 247.32 | 10.99% |
| 2023-08-18 | 12 | 285 | 215 | 254.000 | 214.43 | 18.45% |
| 2023-10-09 | 12 | 285 | 210 | 248.166 | 202.41 | 22.61% |
| 2023-10-17 | 12 | 270 | 210 | 244.000 | 202.95 | 20.23% |
| 2023-10-18 | 12 | 270 | 210 | 244.000 | 201.75 | 20.94% |
LH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 9 | 1 | 3 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
LH's average broker recommendation rating improved by 0.29 over the prior 26 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how LABORATORY CORP OF AMERICA HOLDINGS fares relative to all US stocks, note that its average analyst price target is greater than 5927.74% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, LABORATORY CORP OF AMERICA HOLDINGS's variance in analysts' estimates is lower than -1017.3% of them.
- In terms of how LABORATORY CORP OF AMERICA HOLDINGS fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 1993.1% of that group.
- In terms of how LABORATORY CORP OF AMERICA HOLDINGS fares relative to Healthcare stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2024.67% of that group.
In the Healthcare industry, GH, NTRA, and LFST are the three stocks most similar to LABORATORY CORP OF AMERICA HOLDINGS regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is LH a Buy, Hold or Sell? See the POWR Ratings now!